直近一年間の累計
アクセス数 : ?
ダウンロード数 : ?
ID 118742
タイトル別表記
腎血流量を低下させる薬剤を含む複数の腎毒性を有する薬の併用はバンコマイシン関連腎障害を引き起こす : 2つのリアルワールドデータベースを組み合わせた後方視的研究
Nephrotoxicity with VCM and Nephrotoxins
著者
坂東, 貴司 徳島大学大学院医学研究科(医学専攻)
中馬, 真幸 Tokushima University|Asahikawa Medical University
Kondo, Masateru Tokushima University
Izumi, Yuki Tokushima University
Ishida, Shunsuke Tokushima University
Yoshioka, Toshihiko Tokushima University
Asada, Mizuho Meiji Pharmaceutical University
武智, 研志 Matsuyama University
Miyata, Koji Tokushima University
Tasaki, Yoshikazu Asahikawa Medical University
キーワード
vancomycin-associated nephrotoxicity
polypharmacy
nephrotoxin
spontaneous adverse event reporting database
electronic medical records
資料タイプ
学位論文
抄録
There is a growing concern about the relationship between vancomycin-associated nephrotoxicity (VAN) and concomitant use of nephrotoxins. We examined this relationship by combined retrospective analyses of two real-world databases. Initially, the FDA Adverse Event Reporting System (FAERS) was analyzed for the effects of concomitant use of one or more nephrotoxins on VAN and the types of combinations of nephrotoxins that exacerbate VAN. Next, electronic medical records (EMRs) of patients who received vancomycin (VCM) at Tokushima University Hospital between January 2006 and March 2019 were examined to confirm the FAERS analysis. An elevated reporting odds ratio (ROR) was observed with increases in the number of nephrotoxins administered (VCM + one nephrotoxin, adjusted ROR (95% confidence interval [CI]) 1.67 [1.51–1.85]; VCM + ≥ 2 nephrotoxins, adjusted ROR [95% CI] 1.54 [1.37–1.73]) in FAERS. EMRs analysis showed that the number of nephrotoxins was associated with higher incidences of VAN [odds ratio: 1.99; 95% CI: 1.42–2.78]. Overall, concomitant use of nephrotoxins was associated with an increased incidence of VAN, especially when at least one of those nephrotoxins was a renal hypoperfusion medication (furosemide, non-steroidal anti-inflammatory drugs, and vasopressors). The concomitant use of multiple nephrotoxins, especially including renal hypoperfusion medication, should be avoided to prevent VAN.
掲載誌名
Acta Medica Okayama
ISSN
0386300X
cat書誌ID
AA00508441
出版者
Okayama University Medical School
77
6
開始ページ
595
終了ページ
605
発行日
2023-12
備考
内容要旨・審査要旨・論文本文の公開
本論文は,著者Takashi Bandoの学位論文として提出され,学位審査・授与の対象となっている。
利用は著作権の範囲内に限られる。
権利情報
CopyrightⒸ 2023 by Okayama University Medical School
EDB ID
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
博士論文全文を含む
文科省報告番号
甲第3761号
学位記番号
甲医第1586号
学位授与年月日
2023-10-26
学位名
博士(医学)
学位授与機関
徳島大学
部局
病院
医学系
薬学系